Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

OpGen Inc. (OPGN)

1.63   -0.04 (-2.4%) 02-14 16:00
Open: 1.67 Pre. Close: 1.67
High: 1.684 Low: 1.61
Volume: 202,979 Market Cap: 9M
OpGen Inc is an precision medicine company using molecular diagnostics and bioinformatics to help combat infectious disease.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.682 - 1.696 1.696 - 1.705
Low: 1.582 - 1.597 1.597 - 1.607
Close: 1.61 - 1.634 1.634 - 1.649

Technical analysis

as of: 2020-02-14 4:31:22 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 2.60     One year: 3.31
Support: Support1: 1.25    Support2: 1.04
Resistance: Resistance1: 2.23    Resistance2: 2.83
Pivot: 1.72
Moving Average: MA(5): 1.71     MA(20): 1.72
MA(100): 2.53     MA(250): 7.64
MACD: MACD(12,26): 0.06     Signal(9): 0.08
Stochastic oscillator: %K(14,3): 19.21     %D(3): 22.22
RSI: RSI(14): 49.26
52-week: High: 31.80  Low: 0.92  Change(%): -94.5
Average Vol(K): 3-Month: 97986  10-Days: 216416

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
OPGN has closed above bottom band by 39.0%. Bollinger Bands are 53.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to OPGN's normal range. The bands have been in this narrow range for 63 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

OpGen Takes a Different Approach to the Coronavirus
No summary available.

The Daily Biotech Pulse: Melinta Crosses FDA Hurdle But Sees Liquidity Pushback, Positive Readout For Aclaris Wart Drug
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 24) AstraZeneca plc (NYSE: AZN ) (reacted to a beat-and-raise quarter) Edwards Lifesciences Corp (NYSE: EW )( reported better-than-expected third-quarter results) Frequency Therapeutics Inc (NASDAQ: FREQ ) (IPOed Oct. 3) GlaxoSmithKline plc (NYSE: GSK )(FDA approved expanded use of Zejula) Novo Nordisk A/S (NYSE: NVO ) Down In The Dumps (Biotech stocks hitting 52-week lows on Oct. 24) Acorda Therapeutics Inc NASDAQ: ACOR) (announced restructuring plan, including the elimination of 25% of its workforce) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) bluebird bio Inc (NASDAQ: BLUE ) (announced resignation of chief strategy officer) Brickell Biotech Inc (NASDAQ: BBI ) CytomX Therapeutics Inc (NASDAQ: CTMX ) Diffusion Pharmaceuticals Inc (NASDAQ: DFFN ) Gritstone Oncology Inc (NASDAQ: GRTS ) KemPharm Inc (NASDAQ: KMPH ) MacroGenics Inc (NASDAQ: MGNX ) Midatech Pharma PLC-ADR (NASDAQ: MTP ) OpGen Inc (NASDAQ: OPGN ) )(announcing pricing of previously-announced underwritten common stock offering) Opko Health Inc. (NASDAQ: OPK )(announced a follow-on offering) Orgenesis Inc (NASDAQ: ORGS ) Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN ) Titan Medical Inc. (NASDAQ: TMDI ) Stocks In Focus Melinta Gets FDA Nod For Baxdela Label Expansion; Launch to Be Delayed Due to Liquidity Concerns Melinta Therapeutics Inc (NASDAQ: MLNT ) announced FDA approval for Baxdela for the treatment of adult patients with community-acquired bacterial pneumonia, or CABP, caused by designated succeptible bacteria.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Diagnostics Research
Shares Out. (M) 5.58
Shares Float (M) 2.99
% Held by Insiders 0.35
% Held by Institutions 12.60
Shares Short (K) 52
Shares Short P. Month (K)

Stock Financials

EPS -20.720
Book Value (p.s.) -1.760
PEG Ratio
Profit Margin
Operating Margin -360.43
Return on Assets (ttm) -98.9
Return on Equity (ttm) -1105.0
Qtrly Rev. Growth 17.4
Gross Profit (p.s.) -0.821
Sales Per Share
EBITDA (p.s.) -2.057
Qtrly Earnings Growth
Operating Cash Flow (M) -10.75
Levered Free Cash Flow (M) -5.45

Stock Valuations

P/E -0.08
P/E Growth Ratio -0.02
P/BV -0.93
P/S 0.31
P/CF -0.85

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2019-08-28
Last Split Ratio 0.05
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.